Copyright
©The Author(s) 2020.
World J Diabetes. Oct 15, 2020; 11(10): 468-480
Published online Oct 15, 2020. doi: 10.4239/wjd.v11.i10.468
Published online Oct 15, 2020. doi: 10.4239/wjd.v11.i10.468
Ref. | Survey period | Sample size | Location | Age (mean or median) | Sex (male, %) | Prevalence of diabetes (%) | Quality score |
Chen et al[17] | 2020.1.1-2020.1.20 | 99 | Wuhan China | 55.5 | 67.68 | 12.12 | 7 |
Huang et al[1] | 2019.12.16-2010.1.2 | 41 | Wuhan China | 49.0 | 73.17 | 19.51 | 7 |
Liu et al[18] | 2019.12.30-2020.1.24 | 137 | Wuhan China | 57 | 44.53 | 10.22 | 7 |
Wang et al[19] | 2020.1-2020.1.31 | 138 | Wuhan China | 56 | 54.35 | 10.14 | 7 |
Zhang et al[20] | 2020.1.06-2020.2.3 | 140 | Wuhan China | 57 | 50.71 | 12.14 | 7 |
Chen et al[21] | 2019.1 -2020 .2 | 150 | Wuhan China | 59 | 56.00 | 13.33 | 5 |
Guan et al[22] | 2020.12.11-1.31 | 1590 | China | 48.9 | 56.86 | 8.18 | 9 |
Guo et al[23] | 2020.1.23-2020.2.23 | 187 | Wuhan China | 58.5 | 48.66 | 14.97 | 7 |
Guo et al[4] | 2020.2.10-2020.2.29 | 174 | Wuhan China | 59 | 43.68 | 21.26 | 6 |
Huang et al[9] | 2019.12.21-2020.1.28 | 34 | Wuhan China | 56.24 | 41.18 | 11.76 | 4 |
China CDC[24] | As of 2020.2.11 | 44672 | China | - | 51.44 | 2.47 | 6 |
Lian et al[8] | 2020.1.17-2020.2.12 | 788 | Zhejiang China | 45.8 | 51.65 | 7.23 | 7 |
Shi et al[7] | As of 2020.2.17 | 487 | Zhejiang China | 46 | 53.18 | 5.95 | 3 |
Li et al[25] | 2020.1.18-2020.2.7 | 78 | Zhuhai China | 44.6 | 48.72 | 5.13 | 5 |
Liu et al[3] | 2020.1.15-2020.2.18 | 56 | Hainan China | 53.75 | 55.36 | 7.14 | 6 |
Wan et al[26] | 2020.1.23-2020.2.28 | 135 | Chongqing China | 47 | 53.33 | 8.89 | 5 |
Wang et al[27] | 2020.1.21-2020.2.5 | 18 | Zhengzhou China | 39 | 55.56 | 16.67 | 5 |
Wu et al[28] | 2019.12.25-2020.1.26 | 201 | Wuhan China | 51 | 63.68 | 10.95 | 7 |
Xu et al[29] | 2020.1.23-2020.2.4 | 90 | Guangzhou China | 50 | 43.33 | 5.56 | 6 |
Yuan et al[30] | 2020.1.11-2020.2.4 | 94 | Shenzhen China | 40 | 44.68 | 5.32 | 6 |
Yuan et al[31] | 2020.1.1-2020.1.25 | 27 | Wuhan China | 60 | 44.44 | 22.22 | 5 |
Zhao et al[32] | 2020.1.23-2020.1.31 | 37 | Wuhan China | 41 | 37.84 | 10.81 | 6 |
Zhou et al[33] | 2019.12.29-2020.1.31 | 191 | Wuhan China | 56 | 62.30 | 18.85 | 7 |
Item | Number of studies | Sample size | Diabetes | Prevalence(95%CI, %) | I2 | P values | |
Heterogeneity | Subgroup difference | ||||||
Overall | 23 | 49564 | 1573 | 10 (7-15) | 97% | < 0.01 | - |
Subgroup analysis | |||||||
Sample size | 0.002 | ||||||
≤ 100 | 10 | 574 | 55 | 9 (6-11) | 28% | 0.14 | |
100-200 | 8 | 1252 | 178 | 14 (11-16) | 60% | 0.02 | |
> 200 | 5 | 49588 | 1340 | 7 (4-9) | 94% | < 0.0001 | |
Location | < 0.0001 | ||||||
Wuhan, China | 13 | 1556 | 222 | 14 (12-16) | 35% | 0.12 | |
Outside of Wuhan, China | 8 | 1746 | 119 | 7 (6-8) | 0% | 0.79 | |
China (all cities) | 2 | 46262 | 1432 | 5 (0-11) | 99% | < 0.0001 | |
Age group | < 0.0001 | ||||||
≤ 50 yr | 10 | 3358 | 257 | 7 (6-8) | 10% | 0.27 | |
> 50 yr | 12 | 1534 | 214 | 13 (11-16) | 45% | 0.05 | |
ICU admission | 0.94 | ||||||
ICU | 2 | 112 | 20 | 15 (4-26) | 47% | 0.17 | |
Non-ICU | 2 | 1519 | 118 | 14 (3-35) | 78% | 0.03 | |
Severity | < 0.0001 | ||||||
Severe | 8 | 553 | 99 | 17 (14-20) | 0% | 0.92 | |
Non-severe | 7 | 2190 | 143 | 6 (5-8) | 41% | 0.05 | |
Death | 0.02 | ||||||
Death | 5 | 1146 | 120 | 30 (13-46) | 89% | < 0.0001 | |
Survival | 5 | 45508 | 1191 | 8 (2-15) | 99% | < 0.0001 |
- Citation: Du M, Lin YX, Yan WX, Tao LY, Liu M, Liu J. Prevalence and impact of diabetes in patients with COVID-19 in China. World J Diabetes 2020; 11(10): 468-480
- URL: https://www.wjgnet.com/1948-9358/full/v11/i10/468.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i10.468